{"id":44495,"date":"2022-05-31T13:01:30","date_gmt":"2022-05-31T11:01:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/"},"modified":"2022-05-31T13:01:30","modified_gmt":"2022-05-31T11:01:30","slug":"abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/","title":{"rendered":"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference"},"content":{"rendered":"
\n

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc<\/a>. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd<\/sup> Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT.\n<\/p>\n

<\/a><\/p>\n

\nABOUT ABIOMED<\/b>\n<\/p>\n

\nBased in Danvers, Massachusetts, USA, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and\/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com<\/a>.\n<\/p>\n

\nFORWARD-LOOKING STATEMENTS<\/b>\n<\/p>\n

\nAny forward-looking statements are subject to risks and uncertainties such as those described in Abiomed’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor:<\/b>
Todd Trapp
\n
Vice President and Chief Financial Officer
\n
+1 (978) 646-1680
\n
ttrapp@abiomed.com<\/a><\/p>\n

Media:<\/b>
Jenny Leary
\n
Associate Director, U.S. Communications
\n
+1 (978) 882-8491
\n
jleary@abiomed.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-44495","format-standard","category-industry"],"yoast_head":"\nAbiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-31T11:01:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220531005131\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference\",\"datePublished\":\"2022-05-31T11:01:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/\"},\"wordCount\":178,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005131\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/\",\"name\":\"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005131\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\",\"datePublished\":\"2022-05-31T11:01:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005131\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005131\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/","og_locale":"en_US","og_type":"article","og_title":"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference - Pharma Trend","og_description":"DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-31T11:01:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220531005131\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference","datePublished":"2022-05-31T11:01:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/"},"wordCount":178,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220531005131\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/","url":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/","name":"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220531005131\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","datePublished":"2022-05-31T11:01:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220531005131\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220531005131\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/abiomed-to-present-live-at-the-william-blair-42nd-annual-growth-stock-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44495"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44495\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}